Development of human neutralizing monoclonal antibodies for prevention and therapy of MERS-CoV infections

The recent Middle East respiratory syndrome coronavirus (MERS-CoV) outbreak poses a serious threat to public health. Here, we summarize recent advances in identifying human neutralizing monoclonal antibodies (mAbs) against MERS-CoV, describe their mechanisms of action, and analyze their potential fo...

Descripción completa

Detalles Bibliográficos
Autores principales: Ying, Tianlei, Li, Haoyang, Lu, Lu, Dimitrov, Dimiter S., Jiang, Shibo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Institut Pasteur. Published by Elsevier Masson SAS 2015
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4308519/
https://www.ncbi.nlm.nih.gov/pubmed/25456101
http://dx.doi.org/10.1016/j.micinf.2014.11.008

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4308519/
https://www.ncbi.nlm.nih.gov/pubmed/25456101
http://dx.doi.org/10.1016/j.micinf.2014.11.008

Ejemplares similares